Pictet Asset Management
RVMD icon

Pictet Asset Management’s Revolution Medicines RVMD Stock Holding History

Pictet Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.6M Sell
557,560
-579,561
-51% -$58.5M 0.06% 301
2025
Q4 		$90.7M Sell
1,137,121
-174,620
-13% -$11.4M 0.09% 235
2025
Q3 		$61.2M Buy
1,311,741
+299,781
+30% +$11.7M 0.06% 284
2025
Q2 		$37.2M Buy
1,011,960
+264,400
+35% +$10.2M 0.04% 368
2025
Q1 		$26.4M Buy
747,560
+34,964
+5% +$1.42M 0.03% 424
2024
Q4 		$31.2M Buy
712,596
+696,759
+4,400% +$35.2M 0.03% 389
2024
Q3 		$717K Buy
15,837
+1,050
+7% +$45.7K ﹤0.01% 1189
2024
Q2 		$574K Buy
14,787
+2,255
+18% +$84.3K ﹤0.01% 1218
2024
Q1 		$404K Buy
+12,532
New +$371K ﹤0.01% 1400

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pictet Asset Management's RVMD Position: Q1 2026 in Review

Pictet Asset Management reduced its Revolution Medicines (RVMD) stake by 51% in Q1 2026, selling an estimated $58.5M and leaving 557,560 shares worth $53.6M. The position accounts for 0.06% of the portfolio, ranked #301.

Pictet Asset Management first reported a position in RVMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $90.7M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Pictet Asset Management held 557,560 shares of Revolution Medicines worth $53.6M as of Q1 2026.
  • Pictet Asset Management sold 579,561 Revolution Medicines shares in Q1 2026, an estimated $58.5M.
  • Revolution Medicines made up 0.06% of Pictet Asset Management's portfolio in Q1 2026, its #301 holding.
  • Pictet Asset Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 9 quarters since.
  • Pictet Asset Management's Revolution Medicines position peaked at $90.7M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.